PubMed=23479617; DOI=10.1073/pnas.1219920110; PMCID=PMC3612627
Siddle H.V.T., Kreiss A., Tovar Lopez C.D., Yuen C.K., Cheng Y.-Y., Belov K., Swift K., Pearse A.-M., Hamede R., Jones M.E., Skjodt K., Woods G.M., Kaufman J.
Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer.
Proc. Natl. Acad. Sci. U.S.A. 110:5103-5108(2013)

PubMed=25708088; DOI=10.1016/j.vaccine.2015.01.039
Kreiss A., Brown G.K., Tovar Lopez C.D., Lyons A.B., Woods G.M.
Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Vaccine 33:3016-3025(2015)

PubMed=27936237; DOI=10.1371/journal.pone.0168068; PMCID=PMC5148113
Patchett A.L., Darby J.M., Tovar Lopez C.D., Lyons A.B., Woods G.M.
The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines.
PLoS ONE 11:E0168068-E0168068(2016)

PubMed=32937435; DOI=10.1126/sciadv.aba5031; PMCID=PMC7458443
Flies A.S., Darby J.M., Lennard P.R., Murphy P.R., Ong C.E.B., Pinfold T.L., De Luca A., Lyons A.B., Woods G.M., Patchett A.L.
A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers.
Sci. Adv. 6:eaba5031.1-eaba5031.13(2020)